Casey Pinch, PA
Medical · Gig Harbor, WANPI 1083031025
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 459 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 28.0% of the total. 2025 is the largest year on record at $2,092, 7.6 times the $275 reported in 2021. Among medical clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 459 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- Pfizer$735
- E.r. Squibb & Sons, L.L.C.$449
- Sun Pharmaceutical Industries Inc.$429
- Regeneron Healthcare Solutions, Inc.$385
- plus $1K from 13 others
What the payments were for
- Food & beverage$6,36693%
- Education$4577%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 111 | $1,909 |
| AbbVie | 143 | $1,466 |
| Pfizer | 65 | $735 |
| E.r. Squibb & Sons, L.L.C. | 23 | $449 |
| Sun Pharmaceutical Industries Inc. | 20 | $429 |
| Regeneron Healthcare Solutions, Inc. | 21 | $385 |
| Novartis | 17 | $252 |
| Sanofi | 5 | $192 |
| Incyte Corporation | 9 | $185 |
| Amgen | 6 | $154 |
| UCB, Inc. | 8 | $148 |
| Galderma Laboratories, L.p. | 5 | $110 |
| LEO Pharma Inc. | 5 | $91 |
| Arcutis Biotherapeutics, Inc. | 5 | $89 |
| Dermavant Sciences, Inc. | 5 | $85 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $55 |
| Organon | 5 | $44 |
| Boehringer Ingelheim | 1 | $34 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
How this compares
$6,823 in reported general payments places this provider in the 90th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 27 | $528,195 |
| Dupixent PenDupilumab | 54 | $198,555 |
| Fluorouracil | 98 | $6,022 |
| Clobetasol Propionate | 134 | $3,561 |
| Metronidazole | 101 | $3,550 |
| Betamethasone Dipropionate | 110 | $3,182 |
| Ketoconazole | 102 | $1,662 |
| Triamcinolone Acetonide | 171 | $1,645 |
| Fluocinonide | 40 | $1,290 |
| Doxycycline Hyclate | 65 | $1,048 |
| Mupirocin | 73 | $657 |
| Econazole Nitrate | 28 | $589 |
| Clindamycin Phosphate | 15 | $399 |
| ValacyclovirValacyclovir Hcl | 29 | $276 |
| Hydrocortisone | 46 | $196 |
Paid to pharmacies, not to this prescriber.
Other medical in Gig Harbor
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Salvador LopezYakima$17K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
- Julia TaylorSpokane$12K
- Kristine WesselsSpokane$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.